Psychedelics such as LSD and magic mushrooms have evolved from countercultural rebellion to corporate IPOs. Here's an update. Read More

Marijuana legalization continues apace at the state level, but many lawmakers in Washington, DC harbor long-standing biases against weed. Read More

New federal data show that financial institutions are turning their backs on weed companies. Here’s what the cash crunch means for investors. Read More

Decriminalization of psychedelics is gaining momentum, with drug companies involved in LSD and magic mushrooms launching IPOs. Read More

A congressional vote on a long-stalled bill to decriminalize marijuana at the federal level is about to occur, marking an historic moment for cannabusiness. Read More

A new report from the Centers for Disease Control and Prevention obliterates the argument that marijuana legalization promotes greater use among teens. Read More

Politicians this week are condemning marijuana legalization, which could pose an obstacle for cannabusiness. Here’s what it means for investors. Read More

Criminal justice professionals from across the country are urging Congress to legalize marijuana. That’s a boon for pot investors. Read More

A psychedelic compound is infecting cicadas and forcing them into weird behavior, which in turn is opening a profitable path in drug research. Read More

Marijuana and psychedelics get most of the media attention, but oft-ignored hemp is a fertile source of investment gains. Read More